Metformin attenuates expression of angiogenic and inflammatory genes in human endometriotic stromal cells
article
OA: closed
CC0
⤵ 4 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
Metformin was found to reduce the expression of genes related to angiogenesis and inflammation in human endometriotic stromal cells.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (27)
- Association between macrophage migration inhibitory factor in the endometrium and estrogen in endometriosis via openalex
- Endometriosis via openalex
- Endometriosis and Risk of Adverse Pregnancy Outcomes via openalex
- Expression of MMIF, HIF-1α and VEGF in Serum and Endometrial Tissues of Patients with Endometriosis via openalex
- Expression of vascular endothelial growth factor A isoforms is dysregulated in women with endometriosis via openalex
- Increased Circulating MMP-2 Levels in Infertile Patients With Moderate and Severe Pelvic Endometriosis via openalex
- Is Endometriosis More Common and More Severe Than It Was 30 Years Ago? via openalex
- Macrophage migration inhibitory factor as a potential biomarker of endometriosis via openalex
- Matrix metalloproteinase-2 (MMP-2), MMP-9, tissue inhibitor of matrix metalloproteinases (TIMP-1) and transforming growth factor-β2 (TGF-β2) expression in eutopic endometrium of women with peritoneal endometriosis via openalex
- Metformin as a new therapy for endometriosis, its effects on both clinical picture and cytokines profile via openalex
- Metformin inhibits growth of eutopic stromal cells from adenomyotic endometrium via AMPK activation and subsequent inhibition of AKT phosphorylation: a possible role in the treatment of adenomyosis via openalex
- Metformin regresses endometriotic implants in rats by improving implant levels of superoxide dismutase, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-2, and matrix metalloproteinase-9 via openalex
- Regulation of Inflammation Pathways and Inflammasome by Sex Steroid Hormones in Endometriosis via openalex
- Rethinking mechanisms, diagnosis and management of endometriosis via openalex
- The effects of metformin and letrozole on endometriosis and comparison of the two treatment agents in a rat model via openalex
- The role of inflammation, oxidative stress, angiogenesis, and apoptosis in the pathophysiology of endometriosis: Basic science and new insights based on gene expression via openalex
- W6715081954 via openalex
- W2026967508 via openalex
- W2055452548 via openalex
- W2057298326 via openalex
- W2057684012 via openalex
- W2093664485 via openalex
- W2125747634 via openalex
- W2198636128 via openalex
- W2410880911 via openalex
- W6660617731 via openalex
- W6683013767 via openalex
Cited by (4)
- The role of metformin in the management of endometriosis: A systematic review and meta-analysis 2023
- Advances in Metformin for Treatment of En-dometriosis 2023
- Metformin as a Potential Treatment Option for Endometriosis 2022
- Metformin Prevents Endothelial Dysfunction in Endometriosis through Downregulation of ET-1 and Upregulation of eNOS 2022
Source provenance
- europepmc
- last seen: 2026-06-28T06:08:18.748782+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:24:37.768885+00:00
- unpaywall
- last seen: 2026-06-13T06:42:57.164913+00:00
License: CC0
· commercial use OK